amikacin has been researched along with Glucose Intolerance in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamagami, K; Honma, T; Iwabu, M; Kadowaki, T; Kimura-Someya, T; Matsuda, K; Nagano, T; Ogata, H; Okada-Iwabu, M; Shirouzu, M; Tanabe, H; Tanaka, A; Tokuyama, K; Ueki, K; Yamaguchi, M; Yamauchi, T; Yokoyama, S | 1 |
1 other study(ies) available for amikacin and Glucose Intolerance
| Article | Year |
|---|---|
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
Topics: Adenylate Kinase; Adiponectin; Adipose Tissue, White; Administration, Oral; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Evaluation, Preclinical; Dyslipidemias; Enzyme Activation; Glucose Intolerance; Inflammation; Insulin Resistance; Liver; Longevity; Mice; Mitochondria; Muscle Fibers, Skeletal; Muscles; Obesity; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Piperidines; PPAR alpha; Receptors, Adiponectin; Signal Transduction; Small Molecule Libraries; Transcription Factors; Triglycerides | 2013 |